Psychological and social factors of adherence to treatment in patients with myocardial infarction

by E V Gorbunova, D Yu Sedykh, S A Maksimov
Published 2018-12-01

Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Keme...

by D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash
Published 2020-01-01

Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome

by R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh
Published 2020-12-01

Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries

by O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich
Published 2020-05-01

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris

by V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova
Published 2019-11-01

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders

by O. L. Barbarash, N. V. Fedorova, D. Yu. Sedykh, O. V. Gruzdeva, O. N. Khryachkova, V. V. Kashtalap, A. A. Filimonova
Published 2020-09-01